Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Keurig Dr Pepper Inc.    KDP

KEURIG DR PEPPER INC.

(KDP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

KEURIG DR PEPPER INC. : Other Events, Financial Statements and Exhibits (form 8-K)

11/19/2020 | 04:28pm EST

Item 8.01. Other Events.

On November 19, 2020, Maple Holdings B.V. ("Maple") and Mondel?z International Holdings LLC ("Mondel?z" and, together with Maple, the "Selling Stockholders") completed the previously announced registered public secondary offering (the "Offering") of 60,000,000 shares of common stock, par value $0.01 per share (the "Common Stock"), of Keurig Dr Pepper Inc. (the "Company"), for gross proceeds to the selling stockholders of approximately $1.7 billion. The Company did not receive any proceeds from the sale of the shares of Common Stock by the Selling Stockholder.

Maple is a holding company majority-owned by JAB Holdings B.V..

In connection with the Offering, the Company entered into an Underwriting Agreement, dated November 17, 2020 (the "Underwriting Agreement"), by and among the Company, the Selling Stockholders, and Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC, as the underwriters in the Offering. The Underwriting Agreement is filed as Exhibit 1.1 hereto.

The Company has previously filed with the Securities and Exchange Commission ("SEC") a registration statement (including a prospectus) on Form S-3 (File No. 333-233477) as well as a resale prospectus supplement filed with the SEC on August 27, 2019, as supplemented by a prospectus supplement, filed with the SEC on November 19, 2020, for the Offering.

On November 19, 2020, the Company issued a press release announcing the closing of the Offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.




Exhibits



  1.1      Underwriting Agreement, dated November 17, 2020, by and among Keurig
         Dr Pepper Inc., Maple Holdings B.V., Mondel?z International Holdings
         LLC, and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC.

  99.1     Press Release dated November 19, 2020

104      Cover Page Interactive Data File (the cover page XBRL tags are embedded
         within the Inline XBRL document)




                                       2

© Edgar Online, source Glimpses

All news about KEURIG DR PEPPER INC.
01/22KEURIG DR PEPPER INC. : Change in Directors or Principal Officers, Financial Sta..
AQ
01/21KEURIG DR PEPPER : Announces Appointment of New Director to its Board
PR
01/20KEURIG DR PEPPER : Bernstein Starts Keurig Dr Pepper at Outperform With $40 Pric..
MT
01/12KEURIG DR PEPPER : UBS Adjusts Keurig Dr Pepper's Price Target to $35 From $34, ..
MT
01/07KEURIG DR PEPPER INC. : Ex-dividend day for
FA
01/06KEURIG DR PEPPER : Evercore ISI Downgrades Keurig Dr Pepper to In Line From Outp..
MT
01/04RBC Capital Markets Sees Progress for Beverages, Packaged Food to Start in H2
MT
01/04KEURIG DR PEPPER : RBC Capital Adjusts Keurig Dr Pepper's Price Target to $37 Fr..
MT
2020KEURIG DR PEPPER INC. : Dividends
CO
2020Coca-Cola to Cut 2,200 Jobs
DJ
More news
Financials (USD)
Sales 2020 11 529 M - -
Net income 2020 1 444 M - -
Net Debt 2020 13 058 M - -
P/E ratio 2020 32,2x
Yield 2020 1,84%
Capitalization 45 919 M 45 919 M -
EV / Sales 2020 5,12x
EV / Sales 2021 4,80x
Nbr of Employees 25 500
Free-Float 57,0%
Chart KEURIG DR PEPPER INC.
Duration : Period :
Keurig Dr Pepper Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KEURIG DR PEPPER INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 33,94 $
Last Close Price 32,63 $
Spread / Highest target 28,7%
Spread / Average Target 4,03%
Spread / Lowest Target -17,3%
EPS Revisions
Managers and Directors
NameTitle
Robert James Gamgort Executive Chairman, President & CEO
Ozan Dokmecioglu Chief Financial Officer
David J. Thomas Chief Research & Development Officer
Larry D. Young Director
Dirk van de Put Director
Sector and Competitors